
Kristina Shen
Kristina Shen co-founded Chemistry, a San Francisco early-stage software firm, in 2024 after four years leading business software investing at Andreessen Horowitz and seven years at Bessemer. Chemistry led the Series A of Assort Health, where she is a board observer and which has since become a unicorn.
- Founded
- Chemistry
- Education
- University of California, Berkeley
Track record
Investments Kristina Shen is best known for, with what became of them.
Assort HealthFirm led the Series A; she is a board observerBecame a unicorn
DecagonInvestorBecame a unicorn- SServiceTitanBoard observerListed on Nasdaq in 2024
GlintBoard memberAcquired by LinkedIn in 2018
GainsightBoard observerAcquired by Vista Equity Partners in 2020
InstructureBoard observerListed on the NYSE in 2015
Chemistry
Career
- 2013First met the ServiceTitan founders; she later sat on its board as an observer.
- 2024Co-founded Chemistry with Mark Goldberg and Ethan Kurzweil, after seven years as a partner at Bessemer and four as a general partner at Andreessen Horowitz.
- 2024Chemistry closed its $350M debut fund in October.
- 2026Dealroom lists a $500M second Chemistry fund.
Sources: Chemistry: Kristina Shen · Chemistry · Dealroom: Chemistry · Dealroom: Kristina Shen. Rank: 2026 Strebulaev–Jackson Venture Ranking.
Investments 9
Companies backed, as recorded by Dealroom. Highest company valuations first.









Companies founded

Currently
Active roles, board seats and partnerships.
Work history
Past roles by Dealroom records.




















Education


